US and Canada
The United States is the biggest single prize in Indian exports, and in 2026 it also became the market where the arithmetic changed most often. Tariff rates moved several times in a year, yet orders kept coming, because buyers do not drop a supplier they would have to re-qualify. What holds your place there is how costly you are to replace, not the lowest price. Canada is the smaller, quieter neighbour, with talks restarted and a thin base that makes the case for going early. Both want paperwork done properly. This hub lists the headline numbers, the agreement position, and the regulators to plan around.
Key facts
- US exports
- $87.31B in FY 2025-26; roughly a fifth of India's exports; held #1
- US tariff
- a new 10% duty on top of the normal rate replaced the temporary one on 24 Jul 2026; interim deal not yet signed
- US exemptions
- about 45% of India's exports to America fall outside the 10% duty
- US payment
- open account 30-60d once qualified (insure)
- Canada exports
- $4.22B in FY25
- Canada agreement
- CEPA talks relaunched 27 Feb-2 Mar 2026; fourth round Mumbai Sep 2026; two-way trade in the $50B range by 2030
As of October 2026
Dashboard
Useful links
- US FDA (external link)
food/pharma/device registration
- US CBP (external link)
ISF, rulings (CROSS)